Skip to main content

Table 3 Change in mortality with respect to one-percentage change in PCI recipients at the hospital level

From: Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand

 Change in mortalitya, % (95% CI)
30-day180-day
Crude modelb−0.22* (− 0.11, − 0.33)−0.25* (− 0.15, − 0.35)
Covariate-adjusted modelc−0.21* (− 0.12, − 0.29)−0.20* (− 0.12, − 0.29)
  1. * P < 0.001
  2. a Fixed-effects estimates based on the panel data analysis (n = 156 × 7 hospital-years) and 95% CI based on robust standard error
  3. b Conditional on the number of patients per hospital-year, but no further adjustment by baseline characteristics
  4. c Conditional on the number of patients per hospital-year and adjusted for covariates including patient characteristics (as % of patients): gender, age group (18–59, 60–69, 70–79, and > 80 years), length of hospital stay (1–2, 3–5, and > 6 days), and prior-year hospitalization with key comorbidities (CHF, CVD, CPD and RD)
  5. CHF congestive heart failure; CI confidence interval; CPD chronic pulmonary disease; CVD cerebrovascular disease; PCI percutaneous coronary intervention; RD renal disease